Bill Bishop on why selling H20 chips to China is strategically naive despite Jensen Huang's lobbying wins

Summary

Bill Bishop, author of the Sinocism newsletter, argues that the Trump administration's decision to reverse the H20 chip ban represents a strategic miscalculation driven by access lobbying rather than national security analysis.

The sequence matters. The Biden administration drafted an H20 ban but never enacted it. Trump initially imposed the ban, appearing tougher on China than his predecessor, then reversed course after direct outreach from Jensen Huang to President Trump and David Sacks. Bishop estimates Nvidia spends roughly $1 million on traditional lobbying but routes its real influence through Huang's personal travel schedule and principal-level access, bypassing the interagency process entirely. According to Bishop, the staff who previously worked export control issues were fired, leaving no formal national security review process in place.

The Core Argument Against H20 Sales

Nvidia's lobbying narrative, now dominant in Washington, holds that selling downgraded chips to China keeps Chinese hyperscalers dependent on the US AI stack. Bishop calls this "fundamentally naive." Xi Jinping stated explicitly at a Politburo study session in April 2025 focused on AI that China must build its own indigenous AI stack. The Chinese Communist Party's policy objective is self-reliance, not optimization of compute costs.

Bishop's read is that H20 sales help China close the capability gap while it accelerates efforts to eliminate Nvidia dependency. Alibaba, Tencent, ByteDance, and DeepSeek may prefer Nvidia's CUDA ecosystem in a normal market, but they operate inside a political economy where the party's preferences override commercial logic. Selling H20s now, he argues, maintains Chinese competitiveness in the interim rather than allowing a capability separation to widen.

Huawei's Parallel Track

A Financial Times report cited in the conversation notes that Chinese frontier labs, including DeepSeek, are being encouraged to use Huawei's latest Ascend chips rather than purchase H20s, even at the cost of delayed development timelines. Bishop flags that the Ascend chips are based on dies allegedly fabricated illegally at TSMC through a cutout company linked to Bitmain called Softco, which is said to have obtained approximately 2 million wafers. Huawei engineers are reportedly on-site at Chinese labs working through performance bottlenecks.

The friction around H20 purchases inside China, including regulatory pushback and claims the chips carry backdoors or security risks, Bishop reads not as negotiating tactics for a better chip but as genuine internal pressure to break American semiconductor dependence permanently. Accepting slower near-term progress in exchange for long-run self-sufficiency is consistent with how the party has approached strategic industries historically.

US-China Macro Backdrop

On the broader relationship, Bishop sees a deliberate lull. China's decision to restrict rare earth and rare earth magnet exports early in the trade war demonstrated leverage that Washington had underestimated, and that move effectively paused further US export control escalation. Planned actions on chip-related controls are tabled. A potential Trump-Xi meeting in the fall is being discussed, with speculation about a grand bargain, though Bishop is skeptical given the structural tensions that persist around Taiwan, the South China Sea, and industrial overcapacity.

Rare earths, in his framing, are a high-impact but time-limited card. If the US and allies invest seriously in alternative supply chains, the leverage erodes. The Biden administration identified the problem but produced no solution. Whether the current administration treats it with genuine urgency remains to be seen.

On Chinese business sentiment, Bishop characterizes it as mixed. Foreign chamber of commerce surveys are more pessimistic than in recent years. Domestic confidence has likely bottomed but is not strong. Exceptions include AI-related equities, which are up significantly in 2025, robotics, where government backing and domestic market scale are generating real confidence, and domestic chip stocks, which rallied on news that Chinese labs may avoid H20 purchases.